https://www.avient.com/sites/default/files/2022-11/Packaging Anti-fog Whitepaper.pdf
Whether
a surface coating or an additive concentrate is
selected, the anti-fogging system balances the
differences in surface energies by increasing that
of the film to meet that of the water.
Following a broad screening of potential anti-
fog candidates, production began on a series of
polyethylene films containing the different types
selected, and then laminates were produced with
BOPET using bi-component adhesives.
Various anti-fog additives are available, and
their careful selection depends on the construction of the film in which they are used, as well as the specific
conditions of the application.
https://www.avient.com/sites/default/files/2021-05/avnt-tpe-beginner-guide-fin.pdf
https://www.avient.com/content/product-selection-help-form?
area_of_inquiry=thermoplastic%20elastomers
https://www.avient.com/content/product-selection-help-form?
area_of_inquiry=thermoplastic%20elastomers
https://www.avient.com/content/product-selection-help-form?
https://www.avient.com/sites/default/files/resources/Overmolding_of_Thermoplastic_Elastomers_Engineered_solutions_for_consumer_product_differentiation.pdf
The selection of the type of TPE in
combination of the rigid substrate is the first and foremost.
Spring-Loaded insert for Metal Tolerances
Over-molding Process Selection
The decision which of the possible processes and mold design to select depends on material selected, labor
costs, available tools and machines, production scale economics.
Thinner
Page 5
July 19, 2007
coatings and the selection of a lower hardness over-mold grade will also help.
https://www.avient.com/sites/default/files/2021-04/onflex-s-garden-hose-hand-grip-case-study.pdf
To provide a secure grip
for safety and usability, the company planned to overmold
a thermoplastic elastomer (TPE) onto the handle and other
selected areas of the sprayer.
However, the original TPE that the company selected caused
issues during 2K molding.
https://www.avient.com/sites/default/files/2021-04/bergamid-electronic-connectors-case-study.pdf
Meet targeted cost-performance requirements – The
selected resin must offer significant savings over the
current LCP/carbon fiber formulation through material
and/or manufacturing savings, thus enabling penetration
of the low-cost computer market with a competitive
connector.
After this exhaustive evaluation,
Avient’s solution was selected for two key reasons:
• The Avient material met the targeted cost and
performance targets
• Avient’s approach, support and responsiveness were
exactly the type of partnership the manufacturer needed.
https://www.avient.com/sites/default/files/2022-12/Mevopur Colors for Ophthalmic Closures Application Bulletin_A4.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without animal-
derived substances
• Standard concentrates in a PE carrier and
on request in PP
• Pre-colored formulations can be supplied in
specific resins selected for the application
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III)
• Food contact established with FDA/EU*
APPLICATION BULLETIN
DRUG TYPE COLOR DESCRIPTION
PANTONE
REFERENCE
AVIENT PRODUCT
CODE PE BASED
Adrenergic agonist
combinations
Light Green 373 C PE6M176349
Adrenergic agonists Purple 2583 C PE4M176057
Anti-infectives Tan 467 C PE8M176130
Anti-inflammatory,
nonsteroidal
Grey Cool Grey 4 C PE7M176184
Anti-inflammatory,
steroids
Pink 197 C PE3M176237
Anti-inflammatory,
immunomodulators
Olive Green 5763 C On request
Beta-blockers Yellow Yellow C PE1M176160
Beta-blocker combinations Dark Blue 281 C PE5M176272
Carbonic anhydrase inhibitors Orange 1585 C PE2M176089
Cytotoxic Black 6 C PL9M176008
Miotics Dark Green 348 C PE6M176267
Mydriatics and cycloplegics Red 1797 C PE3M176236
Prostaglandin analogues Turquoise 326 C PE5M176273
Healthcare use limitations apply—see below.
As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
Company Address
17 Tideman Drive, Orangeville (Ontario)
Report Details
NPRI ID
2277
Facility Name
Orangeville Plasticizer
Facility Address
15 Tideman Drive, Orangeville (Ontario)
Update Comments
Activities
Contacts
Select the Facility Contacts
Facility Contacts
Please assign the appropriate contact under each category below.
If you answered “Yes” please select the appropriate reason(s) in the picklist below for why no option was implemented for this substance at
your facility.
Materials or feedstock substitution
Empty
Product design or reformulation
Empty
Equipment or process modifications
Empty
Spill or leak prevention
Empty
Onsite reuse, recycling or recovery
Empty
Improved inventory management or purchasing techniques
Empty
Good operator practice or training
About us News Contact us Stay connected
HEALTH
healthycanadians.gc.ca
TRAVEL
travel.gc.ca
SERVICE CANADA
servicecanada.gc.ca
JOBS
jobbank.gc.ca
ECONOMY
actionplan.gc.ca
Canada.gc.ca
Terms and Conditions Transparency
Version: 3.13.0
Empty
Identify at least one reason why no option to reduce the use or creation of this substance was
implemented at your facility:
Select the applicable reason or reasons **
There are no alternative processes and/or equipment identified, New equipment and/or processes were investigated, however, deemed
unfeasible
Explanation of the reasons why no option will be implemented
Rationale for why the listed options were chosen for implementation
General description of any actions undertaken by the owner and operator of the facility to reduce the use and creation of the toxic substance
at the facility that are outside of the plan
License Number of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this
substance (format TSRPXXXX): *
TSRP0123
Name of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this substance (First
Name Last Name)
Daryl Chartrand
License Number of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (format
TSRPXXXX): *
TSRP0123
Name of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (First Name Last
Name)
Daryl Chartrand
What version of the plan is this summary based on?
https://www.avient.com/sites/default/files/2020-10/demystifing-cmf-brochure.pdf
COLOR, MATERIAL & FINISH DESIGN SERVICE
FIVE WAYS TO BRING CLARITY TO COLOR, MATERIAL
& FINISH SELECTION
D E M Y S T I F Y I N G C M F
FINDING THE RIGHT BALANCE BETWEEN LOOK,
FEEL AND FUNCTION IS IMPORTANT
BUT CHALLENGING
N E A R LY 9 0 % O F A L L P U R C H A S E D E C I S I O N S A R E M A D E S U B CO N S C I O U S LY.
FINDING THE
LATEST
TECHNOLOGIES
VISUALIZING
THE
POSSIBILITIES
HOW CAN I BE SURE I’VE SELECTED THE SOLUTION
THAT’S BEST FOR MY DESIGN AND BRAND?
DESIGN MOTIVATES
D E S I G N I L L U M I N A T E S
VISUALIZING
COLOR, MATERIAL
& FINISH SELECTION
W E ’ V E D E V E LO P E D A TO O L T H AT
A L LO W S Y O U TO S E T T H E C R I T I C A L
FA C TO R S F O R Y O U R P R OJ E C T,
A L LO W I N G Y O U TO M A K E I N T E L L I G E N T
C M F D E C I S I O N S A N D A CC E L E R AT E
D E V E LO P M E N T.
https://www.avient.com/sites/default/files/2022-05/Compensation Committee Charter (REV 10-2019).pdf
The Committee will select a Committee Chair from among its members.
Recommend membership on any selection committee, which may be necessary to fill the
office of Chief Executive Officer.
Independence Assessment of Outside Advisers
• The Committee may select a compensation consultant, legal counsel or other adviser to the
Committee or receive advice from a compensation consultant, legal counsel or other adviser
(other than in-house legal counsel or any compensation consultant, legal counsel or other
adviser whose role is limited to the following activities for which no disclosure would be
required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan
that does not discriminate in scope, terms, or operation, in favor of executive officers or
directors of the Company, and that is available generally to all salaried employees; or
providing information that either is not customized for a particular company or that is
customized based on parameters that are not developed by the compensation consultant, and
about which the compensation consultant does not provide advice) only after taking into
consideration all factors relevant to that person’s independence from management, including
the following:
• the provision of other services to the Company by the employer of the compensation
consultant, legal counsel or other adviser;
5
• the amount of fees received from the Company by the employer of the compensation
consultant, legal counsel or other adviser, as a percentage of the total revenue of the
employer of the compensation consultant, legal counsel or other adviser;
• the policies and procedures of the employer of the compensation consultant, legal counsel
or other adviser that are designed to prevent conflicts of interest;
• any business or personal relationship of the compensation consultant, legal counsel or
other adviser with a member of the Committee;
• any stock of the Company owned by the compensation consultant, legal counsel or other
adviser; and
• any business or personal relationship of the compensation consultant, legal counsel, other
adviser or the employer of the adviser with an executive officer of the Company
https://www.avient.com/sites/default/files/2024-05/Safety goggles - Application snapshot.pdf
https://www.avient.com/products/thermoplastic-elastomers/tpe-knowledge-center/overmolding-guide/overmolding-tpe-selection